Dimension Therapeutics Inc (DMTX)

Not featured in screeners

Not featured in screeners

Ticker: DMTX Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Dimension Therapeutics Inc

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

Planned sale 7 Jun 2016

Value US$1,225,279.18 | Price 360.32 | Shares 16,344 (+26.5%)

Buy 27 Oct 2015

Value US$4,091,628.58 | Price 55.50 | Shares 76,861 (-46.2%)

Buy 27 Oct 2015

Value US$2,600,000.00 | Price 13.00 | Shares 200,000 (+3.8%)

Buy 27 Oct 2015

Value US$2,600,000.00 | Price 13.00 | Shares 200,000 (+3.8%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2016-06-08	2016-06-07	PlS Planned sale	Clark K. Reed SVP of Pharmaceutical Develop Officer	16,344 +26.5% 360.32 US$1,225,279	16,344 +26.5%	360.32	US$1,225,279
2015-10-29	2015-10-27	B Purchase	Dybbs Michael Non-Executive Director	76,861 -46.2% 55.50 US$4,091,629	76,861 -46.2%	55.50	US$4,091,629
2015-10-29	2015-10-27	B Purchase	Gupta Rishi Non-Executive Director Large shareholder	26,933 -47.2% 330.78 US$2,546,449	26,933 -47.2%	330.78	US$2,546,449
2015-10-29	2015-10-27	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	200,000 +3.8% 13.00 US$2,600,000	200,000 +3.8%	13.00	US$2,600,000

More insider trading research around Dimension Therapeutics Inc